SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,084 | -9.8% | 68,324 | +20.9% | 0.00% | 0.0% |
| Q2 2023 | $262,837 | +24.1% | 56,524 | +23.3% | 0.00% | 0.0% |
| Q1 2023 | $211,845 | -58.5% | 45,854 | -27.4% | 0.00% | -50.0% |
| Q4 2022 | $510,042 | +33.9% | 63,124 | -8.1% | 0.00% | 0.0% |
| Q3 2022 | $381,000 | +6.4% | 68,684 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $358,000 | +6.2% | 68,684 | +67.5% | 0.00% | +100.0% |
| Q1 2022 | $337,000 | -44.8% | 41,004 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $610,000 | -21.3% | 41,004 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $775,000 | -4.7% | 41,004 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $813,000 | +172.8% | 43,754 | +47.6% | 0.00% | +300.0% |
| Q3 2020 | $298,000 | +61.1% | 29,641 | +24.3% | 0.00% | 0.0% |
| Q2 2020 | $185,000 | – | 23,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |